Recombinant ITGAV (Abituzumab Biosimilar) antibody

Catalog No. ABIN7597487

This anti-ITGAV (Abituzumab Biosimilar) antibody is a Humanized Chimeric antibody detecting ITGAV (Abituzumab Biosimilar) in . Suitable for Human.

Quick Overview for Recombinant ITGAV (Abituzumab Biosimilar) antibody (ABIN7597487)

Target: ITGAV (Abituzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This ITGAV (Abituzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-ITGAV (Abituzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Abituzumab Biosimilar Antibody

Specificity: MSK8, VNRA, Vitronectin receptor, Integrin alpha-V, Vitronectin receptor subunit alpha, CD51, ITGAV, VTNR

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG2 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for ITGAV (Abituzumab Biosimilar)

Target: ITGAV (Abituzumab Biosimilar)

Alternative Name: Abituzumab Biosimilar

Target Type: Biosimilar

Background: MSK8, VNRA, Vitronectin receptor, Integrin alpha-V, Vitronectin receptor subunit alpha, CD51, ITGAV, VTNR

UniProt: P06756

CAS-No: 1105038-73-0